PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+5.13%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.75B
AUM Growth
+$31.3M
(+1.8%)
Cap. Flow
+$62.9M
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
73.68%
Holding
42
New
–
Increased
21
Reduced
7
Closed
4
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$18.6M |
| 2 |
United Therapeutics
UTHR
|
+$15.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$14M |
| 4 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$13.3M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$5.51M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
+$19M |
| 2 |
CEMP
Cempra, Inc.
CEMP
|
+$7.01M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
+$2.4M |
| 4 |
Talphera
TLPH
|
+$1.56M |
| 5 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
+$962K |
Sector Composition
| 1 | Healthcare | 92.89% |
